AAAAAA

   
Results: 1-9 |
Results: 9
A RANDOMIZED, BLINDED STUDY OF 2 DOSES OF NOVASTAN(R) (BRAND OF ARGATROBAN) VERSUS HEPARIN AS ADJUNCTIVE THERAPY TO RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (ACCELERATED ADMINISTRATION) IN ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE MYOCARDIAL-INFARCTION USING NOVASTAN(R) AND T-PA (MINT) STUDY
Authors: JANG IK GIUGLIANO RP MASSEY TJ SCHWARZ RP
Citation: Ik. Jang et al., A RANDOMIZED, BLINDED STUDY OF 2 DOSES OF NOVASTAN(R) (BRAND OF ARGATROBAN) VERSUS HEPARIN AS ADJUNCTIVE THERAPY TO RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (ACCELERATED ADMINISTRATION) IN ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE MYOCARDIAL-INFARCTION USING NOVASTAN(R) AND T-PA (MINT) STUDY, Journal of thrombosis and thrombolysis, 5(1), 1998, pp. 49-52
THE PRECLINICAL AND CLINICAL-PHARMACOLOGY OF NOVASTAN (ARGATROBAN) - A SMALL-MOLECULE, DIRECT THROMBIN INHIBITOR
Authors: SCHWARZ RP BECKER JCP BROOKS RL HURSTING MJ JOFFRION JL KNAPPENBERGER GD KOGAN TP KOGAN PW MCKINNEY AA
Citation: Rp. Schwarz et al., THE PRECLINICAL AND CLINICAL-PHARMACOLOGY OF NOVASTAN (ARGATROBAN) - A SMALL-MOLECULE, DIRECT THROMBIN INHIBITOR, Clinical and applied thrombosis/hemostasis, 3(1), 1997, pp. 1-15
CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ARGATROBAN TOOPTIMIZE THE ANTICOAGULANT DOSAGE IN INTERVENTIONAL CARDIOVASCULAR PROCEDURES
Authors: LEWIS BE IQBAL O HOPPENSTEADT D AHSAN A AHMAD S MESSMORE HL SCHWARZ RP WALENGA JM
Citation: Be. Lewis et al., CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ARGATROBAN TOOPTIMIZE THE ANTICOAGULANT DOSAGE IN INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Thrombosis and haemostasis, 1997, pp. 2010-2010
EFFECT OF HEPATIC-FUNCTION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN
Authors: HURSTING MJ BECKER JC JOFFRION JL KNAPPENBERGER GD SCHWARZ RP
Citation: Mj. Hursting et al., EFFECT OF HEPATIC-FUNCTION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN, Thrombosis and haemostasis, 1997, pp. 2017-2017
CLINICAL EFFECT OF CONCURRENT WARFARIN ON THE EFFICACY OF ARGATROBAN THERAPY IN HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: BECKER JC HURSTING MJ JOFFRION JL KNAPPENBERGER GD LEWIS BE SCHWARZ RP
Citation: Jc. Becker et al., CLINICAL EFFECT OF CONCURRENT WARFARIN ON THE EFFICACY OF ARGATROBAN THERAPY IN HEPARIN-INDUCED THROMBOCYTOPENIA, Blood, 90(10), 1997, pp. 3205-3205
MONITORING WARFARIN DURING CONCURRENT ARGATROBAN THERAPY IN HEALTHY-VOLUNTEERS - USE OF THE INTERNATIONAL NORMALIZED RATIO VERSUS FACTOR-X BY AMIDOLYTIC ASSAY
Authors: HURSTING MJ BECKER JC JOFFRION JL KNAPPENBERGER GD SCHWARZ RP
Citation: Mj. Hursting et al., MONITORING WARFARIN DURING CONCURRENT ARGATROBAN THERAPY IN HEALTHY-VOLUNTEERS - USE OF THE INTERNATIONAL NORMALIZED RATIO VERSUS FACTOR-X BY AMIDOLYTIC ASSAY, Blood, 90(10), 1997, pp. 3231-3231
PREDICTING WARFARINS CONTRIBUTION TO THE INTERNATIONAL NORMALIZATION RATIO DURING CONCURRENT ARGATROBAN THERAPY
Authors: HURSTING MJ BECKER JC JOFFRION JL KNAPPENBERGER GD SCHWARZ RP
Citation: Mj. Hursting et al., PREDICTING WARFARINS CONTRIBUTION TO THE INTERNATIONAL NORMALIZATION RATIO DURING CONCURRENT ARGATROBAN THERAPY, Blood, 90(10), 1997, pp. 3232-3232
NO EFFECT OF CLOT AGE OR STREPTOKINASE LYSIS ON ARGATROBAN INHIBITIONOF THROMBIN
Authors: HANTGAN RR HURSTING MJ SCHWARZ RP OWEN J
Citation: Rr. Hantgan et al., NO EFFECT OF CLOT AGE OR STREPTOKINASE LYSIS ON ARGATROBAN INHIBITIONOF THROMBIN, Blood, 90(10), 1997, pp. 1320-1320
SUCCESSFUL CORONARY INTERVENTIONS PERFORMED WITH ARGATROBAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS SYNDROME
Authors: LEWIS BE FERGUSON JJ GRASSMAN ED FAREED J WALENGA J JOFFRION JL WRONA L JOHNSON SA SCHWARZ RP MCKIERNAN T
Citation: Be. Lewis et al., SUCCESSFUL CORONARY INTERVENTIONS PERFORMED WITH ARGATROBAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS SYNDROME, The Journal of invasive cardiology, 8(9), 1996, pp. 410-417
Risultati: 1-9 |